STAT3 and plasma cell myeloma: found that MSC-derived exosomes could promote the release of NO from myeloid-derived suppressor cells to enhance their inhibitory effects on T cells through the STAT1 and STAT3 pathways to induce immunosuppression and promote the progression of multiple myeloma (48).